Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [3423]
News [7862]
Articles [63]
Editorials [9]
Conferences [211]
elearning [49]
SABCS 2022: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and survival outcomes
SABCS 2022: The TAILORx trial in over 10,000 women with early breast cancer reaches 12 years of recurrence and...
SABCS 2022: Adding capivasertib to fulvestrant improves progression-free survival in patients with advanced hormone receptor-positive breast cancer
SABCS 2022: Adding capivasertib to fulvestrant improves progression-free survival in patients with advanced...
SABCS 2022: Neoadjuvant trastuzumab deruxtecan shows clinical activity in patients with HER2-low breast cancer
SABCS 2022: Neoadjuvant trastuzumab deruxtecan shows clinical activity in patients with HER2-low breast cancer
SABCS 2022: T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer
SABCS 2022: T-DXd yields longer overall survival than T-DM1 in patients with HER2-positive metastatic breast cancer
IAEA launches worldwide rays of hope partnership with 11 global cancer societies in cancer care
IAEA launches worldwide rays of hope partnership with 11 global cancer societies in cancer care
SABCS 2022: First-line ribociclib plus endocrine therapy may be more effective than combination chemotherapy in patients with aggressive breast cancer
SABCS 2022: First-line ribociclib plus endocrine therapy may be more effective than combination chemotherapy in...
SABCS 2022: HER2-low and HER2-zero triple-negative breast cancer show distinct biological differences
SABCS 2022: HER2-low and HER2-zero triple-negative breast cancer show distinct biological differences
Advancing breast cancer clinical trial design - Prof Hendrik-Tobias Arkenau
Advancing breast cancer clinical trial design - Prof Hendrik-Tobias Arkenau
Research on rare genetic disease sheds light on a common head and neck cancer
Research on rare genetic disease sheds light on a common head and neck cancer
Newfound cancer cell biology suggests which patients will respond to immunotherapy
Newfound cancer cell biology suggests which patients will respond to immunotherapy

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation